JPMorgan Chase & Co’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Sell |
1,777,212
-71,785
| -4% | -$422K | ﹤0.01% | 2185 |
|
|
2025
Q1 | $15.5M | Sell |
1,848,997
-128,222
| -6% | -$1.08M | ﹤0.01% | 1864 |
|
|
2024
Q4 | $14.7M | Buy |
1,977,219
+714,984
| +57% | +$5.32M | ﹤0.01% | 1961 |
|
|
2024
Q3 | $7.32M | Buy |
1,262,235
+861,689
| +215% | +$5M | ﹤0.01% | 2387 |
|
|
2024
Q2 | $2.66M | Buy |
400,546
+22,674
| +6% | +$151K | ﹤0.01% | 2907 |
|
|
2024
Q1 | $4.93M | Buy |
377,872
+1,219
| +0.3% | +$15.9K | ﹤0.01% | 2588 |
|
|
2023
Q4 | $4.8M | Buy |
376,653
+28,085
| +8% | +$358K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $4.57M | Sell |
348,568
-30,545
| -8% | -$400K | ﹤0.01% | 2483 |
|
|
2023
Q2 | $9.7M | Buy |
379,113
+97,910
| +35% | +$2.5M | ﹤0.01% | 2058 |
|
|
2023
Q1 | $7.08M | Buy |
281,203
+47,284
| +20% | +$1.19M | ﹤0.01% | 2229 |
|
|
2022
Q4 | $5.38M | Buy |
233,919
+4,578
| +2% | +$105K | ﹤0.01% | 2329 |
|
|
2022
Q3 | $5.06M | Buy |
229,341
+3,491
| +2% | +$77K | ﹤0.01% | 2330 |
|
|
2022
Q2 | $3.24M | Sell |
225,850
-9,323
| -4% | -$134K | ﹤0.01% | 2695 |
|
|
2022
Q1 | $4.45M | Sell |
235,173
-28,334
| -11% | -$536K | ﹤0.01% | 2638 |
|
|
2021
Q4 | $4.91M | Buy |
263,507
+176,598
| +203% | +$3.29M | ﹤0.01% | 2601 |
|
|
2021
Q3 | $2.34M | Sell |
86,909
-18,905
| -18% | -$508K | ﹤0.01% | 3079 |
|
|
2021
Q2 | $3.31M | Buy |
+105,814
| New | +$3.31M | ﹤0.01% | 2903 |
|